Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases.

Novo Nordisk’s semaglutide will soon be available in a daily pill Americans can take for weight loss.

Smartwatches are cool and all, but have you considered wearable neurotech?

Merge Labs, a brain-computer interface startup that seeks to read brain activity using ultrasound, is being spun out of Forest Neurotech, a Los Angeles nonprofit.

Science Corporation, founded by Neuralink’s first president, Max Hodak, has unveiled a prototype machine to extend the life of organs for longer periods.